BIOPHARMX
BioPharmX, Inc. provides innovative drug-delivery products through its unique, patented platform technologies for pharmaceutical and OTC applications. Its products are designed to address unmet needs in large, well-defined and under-served markets in the fast growing health and wellness markets, including dermatology, women's health and Ear, Nose and Throat (ENT) therapy. The BioPharmX management team consists of Silicon Valley executives, scientists and business professionals combining large... company discipline with deep bio-tech expertise focused on drug delivery and molecular properties. Technical expertise includes pharmaceutical, biological sciences, medical devices and consumer product development with extensive experience in ex vivo/in vitro design, preclinical and clinical development, as well as intellectual property generation. Quality and regulatory expertise includes knowledge of medical directives, US FDA guidance for drugs and medical devices and ICH & IEC guidelines for the US, Canada. China and European Union.
BIOPHARMX
Industry:
Biotechnology Health Care Medical
Founded:
2011-01-01
Address:
Menlo Park, California, United States
Country:
United States
Website Url:
http://www.biopharmx.com
Total Employee:
11+
Status:
Closed
Contact:
(650) 889-5020
Email Addresses:
[email protected]
Total Funding:
20.37 M USD
Technology used in webpage:
SPF Microsoft Exchange Online HostPapa DNS
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Korea Investment Partners
Korea Investment Partners investment in Series A - BioPharmX
More informations about "BioPharmX"
BioPharmX - Crunchbase Company Profile & Funding
BioPharmX, Inc. provides innovative drug-delivery products through its unique, patented platform technologies for pharmaceutical and OTC applications.See details»
BioPharmX Company
BioPharmX is a specialty pharmaceutical company focused on the dermatology market. The company’s focus is to develop products that treat chronic dermatologic conditions that are not …See details»
CORPORATE HEADQUARTERS ABOUT BIOPHARMX NYSE MKT: …
May 31, 2017 BioPharmX Corporation’s strategy is to bring new products to market by identifying optimal delivery mechanisms and/or alternative applications for FDA-approved …See details»
BioPharmX Company Profile 2024: Valuation, Investors ... - PitchBook
BioPharmX Corp specialty pharmaceutical company engaged in utilizing its proprietary drug delivery technologies to develop and commercialize novel prescription products that address …See details»
BioPharmX, Inc. Company Profile | Campbell, CA | Competitors ...
Find company research, competitor information, contact details & financial data for BioPharmX, Inc. of Campbell, CA. Get the latest business insights from Dun & Bradstreet.See details»
BioPharmX - LinkedIn
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing products that treat chronic dermatologic conditions that are not being …See details»
BioPharmX - Contacts, Employees, Board Members, Advisors
Organization. BioPharmX . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of Board …See details»
BioPharmX - Company Profile - Tracxn
1 day ago BioPharmX, a specialty pharmaceutical company, focuses on the development of novel drug delivery products for women's health, dermatology, and otolaryngology markets. It …See details»
BioPharmX Company Profile - Office Locations, Competitors ... - Craft
BioPharmX is a specialty pharmaceutical company focused on utilizing proprietary drug delivery technologies to develop and commercialize novel prescription, over-the-counter and …See details»
BioPharmX - Crunchbase
BioPharmX provides innovative drug-delivery products through its patented platform technologies for pharmaceutical and OTC.See details»
BioPharmX Contact Us
BioPharmX, Inc. 900 E Hamilton Ave, Suite 100 Campbell, CA 95008 650.889.5020. INVESTORS. [email protected]. BUSINESS DEVELOPMENT. …See details»
Home - Biopharmax Group Ltd
Biopharmax is a global design and construction provider of manufacturing facilities and systems for Biotechnology, Pharmaceutical and synthesis API manufacturers.See details»
BioPharmX Corporation and Timber Pharmaceuticals LLC …
Jan 29, 2020 Under the merger agreement, following the merger, (i) the Timber members, including the investors funding the $20 million investment, will own approximately 88.5% of the …See details»
BioPharmX Corporation Announces Approval of Merger by …
May 13, 2020 On February 20, 2020, BioPharmX filed a Registration Statement on Form S-4 with the SEC containing a prospectus and a proxy statement of BioPharmX concerning the …See details»
BioPharmX And Timber Pharmaceuticals Announce Entry into …
Jan 28, 2020 In the exchange, BioPharmX will issue an aggregate of 850,000 shares of common stock to the holders of the warrrants in exchange for out-of-the money warrants to purchase …See details»
BioPharmX - Overview, News & Similar companies | ZoomInfo.com
Who is BioPharmX. At BioPharmX our world leading pharmaceutical and weight loss experts have used their specialist skills and expertise to formulate the most advanc ed and effective range …See details»
BPMX - Biopharmx Corp Stock Price - Barchart.com
BioPharmX Corporation is a specialty pharmaceutical company. The company focuses on the development of novel drug delivery products for women's health, dermatology and …See details»
BioPharmX And Timber Pharmaceuticals Announce Entry into
Jan 28, 2020 SAN JOSE, Calif. and WOODCLIFF LAKE, N.J., Jan. 28, 2020/ PRNewswire/-- BioPharmX Corporation and Timber Pharmaceuticals LLC, a privately held biopharmaceutical …See details»
Overview - BioPharmX
Stabilizes. Hydrophilic: non-occlusive, non-oily; Non-lipophilic (non-oil-based) Suitable for APIs degraded in waterSee details»
BioPharmX In the News
BioPharmX to consider out-licensing acne drug upon well progressed Phase II to begin 1H16 – exec December 22, 2015 BioPharmX Developing Topical Antibiotic Minocycline for Acne …See details»